You are here

Article Text

Article menu

See original article:

Download PDFPDF

Correction
Correction: Gamma delta TCR anti-CD3 bispecific molecules (GABs) as novel immunotherapeutic compounds

https://doi.org/10.1136/jitc-2021-003850corr1

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    van Diest E, Hernández López P, Meringa AD, et al. Gamma delta TCR anti-CD3 bispecific molecules (GABs) as novel immunotherapeutic compounds. J Immunother Cancer 2021;9:e003850. doi:10.1136/jitc-2021-003850.

    This article has been corrected since it was first published. The Abstract section has now been added.